Notes
The study was funded by Takeda Pharmaceuticals International Co.
Reference
Mearns ES, et al. Systematic Literature Review of the Economic Burden of Celiac Disease. PharmacoEconomics : 17 Sep 2018. Available from: URL: http://doi.org/10.1007/s40273-018-0707-5
Rights and permissions
About this article
Cite this article
Burden of coeliac disease: undiagnosed patients costly. PharmacoEcon Outcomes News 813, 5 (2018). https://doi.org/10.1007/s40274-018-5312-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5312-5